Recent breakthroughs in common adult leukemia highlighted in New England Journal of Medicine
When the most common adult leukemia in the United States was last reviewed by the New England Journal of Medicine (NEJM) in 1995, it was seen through the eyes of theories that dated back to the 1960s. As such, the journal recently invited three of the world's foremost experts on chronic lymphocytic leukemia (CLL) to write an authoritative update covering the transformation in the scientific commu...Genome-wide mouse study yields link to human leukemia
Thanks to a handful of very special mice, scientists have discovered a new tumor suppressor gene and a unique chemical signature implicated in the development of human leukemia, findings that open up a "treasure box" of opportunity and possibility, study authors say. Researchers in The Ohio State University Comprehensive Cancer Center bred a type of mouse that develops acute lymphoblastic...Leukemia Drug Breakthrough Study In New England Journal Of Medicine
Alan List, M.D., leader of the Hematologic Malignancies Program at the H. Lee Moffitt Cancer Center & Research Institute, recently conducted a phase I/II trial of the experimental drug Revlimid showing promise as an innovative way to treat patients with myelodysplastic syndrome (MDS), a form of pre-leukemia. Given in pill form, Revlimid simultaneously blocks the growth of new blood vessels th...Enzyme allows B cells to resist death, leading to leukemia
B cell chronic lymphocytic leukemia (B-CLL)is the most common leukemia in adults and is characterized by theprogressive accumulation of mature B lymphocytes in the blood, bonemarrow, and lymphatic tissues. It is believed that in the early stagesof disease, B-CLL is the result of an undefined defect in theprogrammed signals that trigger normal B cell death (apoptosis). LivioTrentin and colle...Genetically modified natural killer immune cells attack, kill leukemia cells
Natural killer (NK) immune system cells can be genetically modified to brandish a powerful "on-switch" that prompts them to aggressively attack and kill leukemic cells. This finding, from researchers at St. Jude Children's Research Hospital, suggests a way to improve the outcome of children who receive treatment for acute lymphoblastic leukemia (ALL) or other blood cancers. Results of the...Leukocytes, human - sonicated from AppliChem GmbH
Description:NOTE: 0.9 ml per liter of urine will give a positive reaction for leukocytes on an Ames or BMD dipstick. Certification: The Donors are of US origin and have been tested and found to be NEGATIVE for HbsAg, HCV, HIV-1 & 2, Syphilis and HIV-1 Antigen by currently approved FDA methods. THIS MATERIAL IS SOLD FOR IN-VITRO DIAGNOSTIC USE ONLY IN MANUFACTURING OR RESEARCH. THIS MATERIAL IS NOT SUI...OPTIMIX KIT FOR EUKARYOTE from Thermo Scientific
Description:OptiBuffer is a fully optimised medium, designed forthe electroporation of eukaryotic cells. OptiBufferimproves both transfection efficiencies and survivalrates over PBS or other standard culture media....Gene Pulser Xcell Eukaryotic System from Bio-Rad
Description:The Gene Pulser Xcell eukaryotic system, 100 to 240 V, 50-60 Hz, is used for electroporation of mammalian cells. This system includes the main unit, CE module for exponential (25-3,275 microfarad range) or square-wave pulses, ShockPod shocking chamber, 5 sterile cuvettes (0.4 cm gap), and instructions....FRT flanked, Pro and Euk. Neomycin Selection Cassette (FRT-PGK-gb2-neo-FRT) from Gene Bridges GmbH
Description:The with a eukaryotic promoter (PGK) for expression of neomycin resistance in mammalian cell...Eppendorf Multiporator Transfection Protocols for Eukaryotic Cells
<A href="http://www.biocompare.com/techart.asp?id=575">Actinobacillus pleuropnomoniae <A href="http://www.biocompare.com/techart.asp?id=576">Actinomyces viscosus <A...Eppendorf Multiporator Transfection Protocols for Eukaryotic Cells
<A href="http://www.biocompare.com/techart.asp?id=575">Actinobacillus pleuropnomoniae <A href="http://www.biocompare.com/techart.asp?id=576">Actinomyces viscosus <A...Simple and Rapid Isolation of Plant RNA Using the Eppendorf Perfect RNA, Eukaryotic, Maxi Kit
Simple and Rapid Isolation of Plant RNA Using the Eppendorf Sonja Vorwerk, Max Planck Institut fr Zchtungsforschung, Carl-von-Linn Weg 10, 50829 Cologne, Germany Phone: ++49-221-5062-441, Fax. ++49-221-5062-413, e-mai...Bacterial RNA Isolation From Infected Eukaryotic Hosts
90% of mammalian RNA from complex mixtures of host-bacterial samples Seamless integration with MICROB <...Bacterial RNA Isolation From Infected Eukaryotic Hosts
90% of mammalian RNA from complex mixtures of host-bacterial samples Seamless integration with MICROB <...GLEEVEC - An Oral treatment for leukemia
The U.S.Food and Drug Administration (FDA) at a conference in Washington, approves the new leukemia drug-GLEEVEC, first of its kind that directly removes the sign of a protein known to cause cancer. It is given as an oral treatment for chronic myelogenous leukemia (CML). Other molecular-targeting drugs previously approved by the FDA interfere with proteins associated with other cancer...GLEEVEC - An Oral treatment for leukemia
The U.S.Food and Drug Administration (FDA) at a conference in Washington, approves the new leukemia drug-GLEEVEC, first of its kind that directly removes the sign of a protein known to cause cancer. It is given as an oral treatment for chronic myelogenous leukemia (CML). Other molecular-targeting drugs previously approved by the FDA interfere with proteins associated with other cancer...Cyclosporin A Treats Leukemia Complications
Some leukemia patients with common complications of their disease may have a new way to overcome them. New research finds that chronic lymphocytic leukemia (CLL) patients with anemia or thrombocytopenia can be treated effectively with the drug, cyclosporin A. Anemia is a decrease in red cells in the blood and thrombocytopenia is when the number of platelets in reduced. The latter is the m...Exposure to EMF may cause leukemia
Long periods of exposure to high level electromagnetic fields (EMF) at home could double the risk of childhood leukemia, a major international study has found. //The three-year review was carried out for the International Commission on Non-Ionizing Radiation Protection (ICNIRP) by six senior epidemiologists from major institutions around the world. Leukemia, which develops in the bone...Blood Bank QC of Leukoreduced Products
Description:ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, maj...Chromosome Analysis, Chronic Lymphocytic Leukemia (CLL) Panel by FISH
Description:ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, maj...Chromosome Analysis, Leukemic Blood
Description:ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, maj...Chronic Lymphocytic Leukemia (CLL)
Description:ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, maj...Santaris Pharma Presents Positive Clinical Data on SPC2996 in Chronic Lymphocytic Leukaemia
First RNA Antagonist Medicine to Be Tested in Patients ReducesSeverity of Adult Leukaemia Copenhagen, 6th June 2007 - Santaris Pharma, the Danishbiopharmaceutical company, announced today that SPC2996, theCompany's new RNA Antagonist of Bcl-2, has shown early evidence ofefficacy in an initial Phase I/II clinical study in ChronicLymphocytic Leukaemia (CLL). The results of the study...Promising Results with Epratuzumab and Chemotherapy in Children with Acute Lymphoblastic Leukemia
- Results from a Children's Oncology Group (COG) Study Presented atAmerican Society of Clinical Oncology Annual Meeting - CHICAGO, June 04, 2007 /PRNewswire-FirstCall/ -- Immunomedics,Inc. , a biopharmaceutical company focused on developing monoclonalantibodies to treat cancer and other serious diseases, todayannounced that treatment with epratuzumab plus standardchemotherapy is feasible...